| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 8888888 |
Internal/system code - not a standard HCPCS code |
17,221 |
7,725 |
$5.01M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
829 |
725 |
$182K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,819 |
4,250 |
$146K |
| 80053 |
Comprehensive metabolic panel |
6,085 |
5,023 |
$112K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,039 |
5,851 |
$110K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,171 |
947 |
$57K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,610 |
1,507 |
$54K |
| 81001 |
|
5,253 |
4,480 |
$44K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,780 |
2,132 |
$39K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,017 |
882 |
$38K |
| 86710 |
|
587 |
547 |
$36K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,059 |
973 |
$30K |
| 71045 |
Radiologic examination, chest; single view |
2,145 |
1,819 |
$27K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,150 |
4,152 |
$24K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
95 |
83 |
$24K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,172 |
1,075 |
$20K |
| 71046 |
Radiologic examination, chest; 2 views |
436 |
376 |
$20K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
524 |
462 |
$19K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
173 |
160 |
$19K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,632 |
1,446 |
$14K |
| 85027 |
|
9,239 |
7,256 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
893 |
797 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,862 |
2,351 |
$7K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,296 |
3,580 |
$6K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,196 |
1,072 |
$6K |
| 83605 |
|
2,744 |
2,129 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
48 |
47 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,782 |
2,203 |
$6K |
| 84484 |
|
1,860 |
1,364 |
$4K |
| 80076 |
|
1,968 |
1,563 |
$3K |
| 81025 |
|
1,112 |
945 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
33 |
24 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,805 |
1,448 |
$3K |
| 83690 |
|
2,742 |
2,256 |
$3K |
| 87077 |
|
169 |
148 |
$3K |
| 80143 |
|
130 |
124 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,513 |
1,356 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,082 |
2,411 |
$2K |
| 96376 |
|
1,535 |
1,150 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
990 |
908 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
716 |
619 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,577 |
949 |
$2K |
| 80305 |
|
220 |
192 |
$2K |
| 84703 |
|
1,412 |
1,263 |
$2K |
| 87081 |
|
70 |
68 |
$1K |
| 82247 |
|
25 |
12 |
$1K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
265 |
204 |
$1K |
| 82550 |
|
801 |
670 |
$1K |
| 84439 |
|
597 |
526 |
$1K |
| 85610 |
|
109 |
78 |
$887.49 |
| 87040 |
|
874 |
637 |
$726.45 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
15 |
15 |
$723.11 |
| 86140 |
|
86 |
67 |
$614.32 |
| G0378 |
Hospital observation service, per hour |
531 |
402 |
$612.12 |
| 86900 |
|
87 |
76 |
$560.81 |
| 80320 |
|
17 |
13 |
$507.13 |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
16 |
15 |
$356.81 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
16 |
13 |
$337.80 |
| 86850 |
|
14 |
12 |
$210.26 |
| 83880 |
|
182 |
156 |
$200.60 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
73 |
64 |
$98.65 |
| 85379 |
|
336 |
301 |
$70.08 |
| 82077 |
|
602 |
544 |
$60.40 |
| 87186 |
|
168 |
148 |
$42.67 |
| 97116 |
|
28 |
25 |
$22.60 |
| J2060 |
Injection, lorazepam, 2 mg |
172 |
144 |
$5.21 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
83 |
58 |
$0.77 |
| J7050 |
Infusion, normal saline solution, 250 cc |
89 |
74 |
$0.67 |
| 80179 |
|
115 |
110 |
$0.00 |
| 87634 |
|
13 |
13 |
$0.00 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
13 |
12 |
$0.00 |
| 87420 |
|
17 |
17 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
49 |
48 |
$0.00 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
24 |
24 |
$0.00 |
| 99152 |
|
58 |
55 |
$0.00 |
| 76376 |
|
74 |
66 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
16 |
13 |
$0.00 |
| 97161 |
|
13 |
13 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
388 |
277 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
118 |
99 |
$0.00 |
| 86901 |
|
87 |
76 |
$0.00 |
| 36000 |
|
59 |
49 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
21 |
13 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
30 |
26 |
$0.00 |
| A9270 |
Non-covered item or service |
45 |
13 |
$0.00 |
| 83735 |
|
15 |
12 |
$0.00 |